Cargando…
Predicting tumour content of liquid biopsies from cell-free DNA
BACKGROUND: Liquid biopsy is a minimally-invasive method of sampling bodily fluids, capable of revealing evidence of cancer. The distribution of cell-free DNA (cfDNA) fragment lengths has been shown to differ between healthy subjects and cancer patients, whereby the distributional shift correlates w...
Autores principales: | Cardner, Mathias, Marass, Francesco, Gedvilaite, Erika, Yang, Julie L., Tsui, Dana W. Y., Beerenwinkel, Niko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543881/ https://www.ncbi.nlm.nih.gov/pubmed/37777714 http://dx.doi.org/10.1186/s12859-023-05478-8 |
Ejemplares similares
-
Inferring signalling dynamics by integrating interventional with observational data
por: Cardner, Mathias, et al.
Publicado: (2019) -
Discovery of antimicrobials by massively parallelized growth assays (Me(x))
por: Koch, Philipp, et al.
Publicado: (2022) -
Predicting cancer type from tumour DNA signatures
por: Soh, Kee Pang, et al.
Publicado: (2017) -
Cell-Free DNA Fragmentomics in Liquid Biopsy
por: Ding, Spencer C., et al.
Publicado: (2022) -
Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma
por: Lyu, Xueying, et al.
Publicado: (2022)